Job Research Foundation, which seeks to help find a cure and treatments for Job Syndrome, has announced the ninth round of grant funding. The Foundation will award up to two grants in the amount of ...

How much a stock's price changes over time is important for most investors, since price performance can both impact your ...

Recently published Alport Syndrome Market Insights report includes a comprehensive understanding of current treatment ...

Atrium Therapeutics, Inc. (the "Company"), a biopharmaceutical company dedicated to delivering RNA therapeutics to the heart, announced today that the U.S. Food and Drug Administration (FDA) has ...

Antiamyloid drugs clear amyloid plaques and modestly slow cognitive decline in patients with Alzheimer’s disease, but whether ...

BBIO's outlook hinges on Attruby growth, upcoming drug launch catalysts and execution as it seeks to diversify beyond its ...

BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, announced ...

Objective Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy characterised by pathological left ...

Learn what an ear pit hole is, why some people are born with one, and what science says about its origins. The post Tiny Hole ...

Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced that it has entered into a Cooperative Research and Development ...

Dementia prevention is becoming a testable public health strategy. The 2024 Lancet Commission on dementia prevention, intervention, and care estimated that about 45% of dementia cases might be ...

Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca today and set a price target of £163.70. TipRanks Welcomes a New ETF – NYSE:RANK. TipRanks has entered ...